Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review

As of August 16, 2021, there have been 207,173,086 confirmed cases and 4,361,996 deaths due to the coronavirus disease (COVID-19), and the pandemic remains a global challenge. To date, no effective and approved drugs are available for the treatment of COVID-19. Angiotensin-converting enzyme 2 (ACE2)...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Bhagat, Singh, Dheer, Verma, Vinod, Yadav, Ramakant, Kumar, Raj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2022
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677424/
https://www.ncbi.nlm.nih.gov/pubmed/34934510
http://dx.doi.org/10.1016/j.jpha.2021.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677424/
https://www.ncbi.nlm.nih.gov/pubmed/34934510
http://dx.doi.org/10.1016/j.jpha.2021.12.003

Ejemplares similares